Conference Roundup

Long-term maralixibat treatment improves height in children with ALGS

Long-term treatment with maralixibat significantly increased height from baseline to week 204 in children with Alagille syndrome (ALGS), according to a poster presented at NASPGHAN 2022. Data from patients who participated in the maralixibat clinical studies and the long-term open-label extensions were used to evaluate height and weight z-scores. The...